logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The concept of innovative drugs is once again on the rise, Haoyuan Medicine has surged more than 15%.

date
29/08/2025
The concept of innovative drugs has risen again, Haoyuan Pharmaceutical's stock has surged over 15%, and KangChen Pharmaceutical and HuaHai Pharmaceutical have hit the daily limit.
Latest
3 m ago
Hong Kong financial advisory company VTA Capital (VTA.US) lowers IPO size, with expected fundraising amount to be reduced by 20%.
3 m ago
Quanfeng Automobile: Net profit in the first half of 2025 was a loss of 167 million yuan.
3 m ago
Lanfan Medical: Net loss of 135 million yuan in the first half of 2025, a year-on-year narrowing of 15.88%
4 m ago
Zhejiang Zhengte: Net profit in the first half of 2025 was 70.5088 million yuan, an increase of 56.03% year-on-year.
5 m ago
Qianjin Pharmaceutical Industry: Net profit in the first half of 2025 increased by 8.50% year-on-year.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.